Scalper1 News
Three big pharmas reported light-to-mixed Q1 earnings Tuesday, but their shares went in different directions in the stock market today as Wall Street seemed to focus on different details of the reports. Bristol-Myers Squibb (BMY) said Q1 earnings rose 12% over the year-earlier quarter to 46 cents a share, beating analysts’ consensus by 3 cents. Sales, however, fell 1% to $3.8 billion, missing consensus of $3.9 billion. Bristol added a nickel to Scalper1 News
Scalper1 News